Share Twitter LinkedIn Facebook Email Heather H. Cheng MD, PhD, Seattle Cancer Care Alliance, discusses Areas of Research in 2018-19 include Combination therapy, CARP Inhibitors, radiopharmaceuticals at Annual Meeting 2018.
Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD Prostate 2 Mins Read
Pioneering Advances in Non-Metastatic Prostate Cancer: Navigating ARPIs and Precision Diagnostics for Tailored Treatment [39 SLIDES] Prostate 5 Mins Read
Promontory Therapeutics: PT-112 triggers organelle stress and ribosomal inhibition Prostate 2 Mins Read